Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to 1.11.

  • Harvard Bioscience's Asset Utilization Ratio rose 4711.78% to 1.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.11, marking a year-over-year increase of 4711.78%. This contributed to the annual value of 0.71 for FY2024, which is 1019.3% down from last year.
  • As of Q3 2025, Harvard Bioscience's Asset Utilization Ratio stood at 1.11, which was up 4711.78% from 1.11 recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Asset Utilization Ratio registered a high of 1.11 during Q2 2025, and its lowest value of 0.68 during Q1 2021.
  • For the 5-year period, Harvard Bioscience's Asset Utilization Ratio averaged around 0.81, with its median value being 0.78 (2022).
  • As far as peak fluctuations go, Harvard Bioscience's Asset Utilization Ratio plummeted by 988.85% in 2024, and later skyrocketed by 4711.78% in 2025.
  • Harvard Bioscience's Asset Utilization Ratio (Quarter) stood at 0.75 in 2021, then grew by 3.09% to 0.78 in 2022, then increased by 4.5% to 0.81 in 2023, then decreased by 9.89% to 0.73 in 2024, then skyrocketed by 51.41% to 1.11 in 2025.
  • Its Asset Utilization Ratio was 1.11 in Q3 2025, compared to 1.11 in Q2 2025 and 0.89 in Q1 2025.